id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3231482,9231bb1e-e2f7-4b3b-a75b-139d71ff8bb4,3T,"WILLIAMS AND JENSEN, PLLC",41454,"INDIVIOR, INC.",2024,third_quarter,HCR,"General education on issues related to the Drug Enforcement Agency (DEA), issues related to substance abuse addiction and treatment, including NIH/HHS funding levels, Issues related to access to addiction treatments, including telehealth. Support Act Reauthorization.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",40000,,0,1,2024-09-27T16:41:22-04:00
3231483,9231bb1e-e2f7-4b3b-a75b-139d71ff8bb4,3T,"WILLIAMS AND JENSEN, PLLC",41454,"INDIVIOR, INC.",2024,third_quarter,TAX,Tax credits and tax issues related to the pharmaceutical industry.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,1,2024-09-27T16:41:22-04:00
3231484,9231bb1e-e2f7-4b3b-a75b-139d71ff8bb4,3T,"WILLIAMS AND JENSEN, PLLC",41454,"INDIVIOR, INC.",2024,third_quarter,BUD,Policies impacting access to substance abuse treatment.,"HOUSE OF REPRESENTATIVES,SENATE,White House Office",40000,,0,1,2024-09-27T16:41:22-04:00
3231485,9231bb1e-e2f7-4b3b-a75b-139d71ff8bb4,3T,"WILLIAMS AND JENSEN, PLLC",41454,"INDIVIOR, INC.",2024,third_quarter,MMM,"Medicaid Re-Entry Act, policies related to reimbursement of substance use disorder treatment and the Mainstreaming Addiction Treatment Act.","HOUSE OF REPRESENTATIVES,SENATE,White House Office",40000,,0,1,2024-09-27T16:41:22-04:00